849 related articles for article (PubMed ID: 22327391)
1. Natural infection with torque teno sus virus 1 (TTSuV1) suppresses the immune response to porcine reproductive and respiratory syndrome virus (PRRSV) vaccination.
Zhang Z; Wang Y; Fan H; Lu C
Arch Virol; 2012 May; 157(5):927-33. PubMed ID: 22327391
[TBL] [Abstract][Full Text] [Related]
2. Protection and immune response in pigs intradermally vaccinated against porcine reproductive and respiratory syndrome (PRRS) and subsequently exposed to a heterologous European (Italian cluster) field strain.
Martelli P; Cordioli P; Alborali LG; Gozio S; De Angelis E; Ferrari L; Lombardi G; Borghetti P
Vaccine; 2007 Apr; 25(17):3400-8. PubMed ID: 17276558
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity.
Martelli P; Gozio S; Ferrari L; Rosina S; De Angelis E; Quintavalla C; Bottarelli E; Borghetti P
Vaccine; 2009 Jun; 27(28):3788-99. PubMed ID: 19442420
[TBL] [Abstract][Full Text] [Related]
4. Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus.
Charerntantanakul W; Platt R; Johnson W; Roof M; Vaughn E; Roth JA
Vet Immunol Immunopathol; 2006 Jan; 109(1-2):99-115. PubMed ID: 16165219
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte activation as cytokine gene expression and secretion is related to the porcine reproductive and respiratory syndrome virus (PRRSV) isolate after in vitro homologous and heterologous recall of peripheral blood mononuclear cells (PBMC) from pigs vaccinated and exposed to natural infection.
Ferrari L; Martelli P; Saleri R; De Angelis E; Cavalli V; Bresaola M; Benetti M; Borghetti P
Vet Immunol Immunopathol; 2013 Feb; 151(3-4):193-206. PubMed ID: 23228653
[TBL] [Abstract][Full Text] [Related]
6. Similarity of European porcine reproductive and respiratory syndrome virus strains to vaccine strain is not necessarily predictive of the degree of protective immunity conferred.
Prieto C; Alvarez E; Martínez-Lobo FJ; Simarro I; Castro JM
Vet J; 2008 Mar; 175(3):356-63. PubMed ID: 17560818
[TBL] [Abstract][Full Text] [Related]
7. Porcine circovirus type 2 infection decreases the efficacy of a modified live porcine reproductive and respiratory syndrome virus vaccine.
Opriessnig T; McKeown NE; Harmon KL; Meng XJ; Halbur PG
Clin Vaccine Immunol; 2006 Aug; 13(8):923-9. PubMed ID: 16893993
[TBL] [Abstract][Full Text] [Related]
8. Protective immunity induced by a recombinant pseudorabies virus expressing the GP5 of porcine reproductive and respiratory syndrome virus in piglets.
Qiu HJ; Tian ZJ; Tong GZ; Zhou YJ; Ni JQ; Luo YZ; Cai XH
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):309-19. PubMed ID: 15963827
[TBL] [Abstract][Full Text] [Related]
9. Positive inductive effect of IL-2 on virus-specific cellular responses elicited by a PRRSV-ORF7 DNA vaccine in swine.
Rompato G; Ling E; Chen Z; Van Kruiningen H; Garmendia AE
Vet Immunol Immunopathol; 2006 Jan; 109(1-2):151-60. PubMed ID: 16162362
[TBL] [Abstract][Full Text] [Related]
10. Effect of vaccination with a modified-live porcine reproductive and respiratory syndrome virus vaccine on dynamics of homologous viral infection in pigs.
Cano JP; Dee SA; Murtaugh MP; Trincado CA; Pijoan CB
Am J Vet Res; 2007 May; 68(5):565-71. PubMed ID: 17472459
[TBL] [Abstract][Full Text] [Related]
11. Effect of modified-live porcine reproductive and respiratory syndrome virus (PRRSv) vaccine on the shedding of wild-type virus from an infected population of growing pigs.
Linhares DC; Cano JP; Wetzell T; Nerem J; Torremorell M; Dee SA
Vaccine; 2012 Jan; 30(2):407-13. PubMed ID: 22063389
[TBL] [Abstract][Full Text] [Related]
12. Immunologic responses and reproductive outcomes following exposure to wild-type or attenuated porcine reproductive and respiratory syndrome virus in swine under field conditions.
Lowe JF; Zuckermann FA; Firkins LD; Schnitzlein WM; Goldberg TL
J Am Vet Med Assoc; 2006 Apr; 228(7):1082-8. PubMed ID: 16579789
[TBL] [Abstract][Full Text] [Related]
13. Impact of a novel inactivated PRRS virus vaccine on virus replication and virus-induced pathology in fetal implantation sites and fetuses upon challenge.
Karniychuk UU; Saha D; Vanhee M; Geldhof M; Cornillie P; Caij AB; De Regge N; Nauwynck HJ
Theriogenology; 2012 Oct; 78(7):1527-37. PubMed ID: 22980086
[TBL] [Abstract][Full Text] [Related]
14. Comparison of different vaccination schedules for sustaining the immune response against porcine reproductive and respiratory syndrome virus.
Díaz I; Gimeno M; Callén A; Pujols J; López S; Charreyre C; Joisel F; Mateu E
Vet J; 2013 Aug; 197(2):438-44. PubMed ID: 23499541
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the efficacy of a new modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine (Fostera PRRS) against heterologous PRRSV challenge.
Park C; Seo HW; Han K; Kang I; Chae C
Vet Microbiol; 2014 Aug; 172(3-4):432-42. PubMed ID: 24970363
[TBL] [Abstract][Full Text] [Related]
16. Impact of a modified-live porcine reproductive and respiratory syndrome virus vaccine intervention on a population of pigs infected with a heterologous isolate.
Cano JP; Dee SA; Murtaugh MP; Pijoan C
Vaccine; 2007 May; 25(22):4382-91. PubMed ID: 17451850
[TBL] [Abstract][Full Text] [Related]
17. Dynamics and evolution of porcine reproductive and respiratory syndrome virus (PRRSV) ORF5 following modified live PRRSV vaccination in a PRRSV-infected herd.
Nilubol D; Tripipat T; Hoonsuwan T; Tipsombatboon P; Piriyapongsa J
Arch Virol; 2014 Jan; 159(1):17-27. PubMed ID: 23851653
[TBL] [Abstract][Full Text] [Related]
18. Cell-mediated immune response and protective efficacy of porcine reproductive and respiratory syndrome virus modified-live vaccines against co-challenge with PRRSV-1 and PRRSV-2.
Madapong A; Saeng-Chuto K; Boonsoongnern A; Tantituvanont A; Nilubol D
Sci Rep; 2020 Feb; 10(1):1649. PubMed ID: 32015495
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Fostera® PRRS modified live virus (MLV) vaccination strategy against a Thai highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) infection.
Charoenchanikran P; Kedkovid R; Sirisereewan C; Woonwong Y; Arunorat J; Sitthichareonchai P; Sopipan N; Jittimanee S; Kesdangsakonwut S; Thanawongnuwech R
Trop Anim Health Prod; 2016 Oct; 48(7):1351-9. PubMed ID: 27315207
[TBL] [Abstract][Full Text] [Related]
20. Recombinant Porcine Reproductive and Respiratory Syndrome Virus Expressing Membrane-Bound Interleukin-15 as an Immunomodulatory Adjuvant Enhances NK and γδ T Cell Responses and Confers Heterologous Protection.
Cao QM; Ni YY; Cao D; Tian D; Yugo DM; Heffron CL; Overend C; Subramaniam S; Rogers AJ; Catanzaro N; LeRoith T; Roberts PC; Meng XJ
J Virol; 2018 Jul; 92(13):. PubMed ID: 29643245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
